Annabella Pardo
The second Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is returning to the Fontainebleau in Miami Beach, Florida, on April 13, 2023.
Enjoy exclusive opportunities for curated networking and unparalleled access to private deal flow at an event hosted by Benzinga, the leader in financial news and data for the psychedelics industry.
Join Benzinga for a day full of unique networking opportunities, exclusive industry insights and a chance to be in the room with the leaders taking psychedelics to the next level.
The Speakers
The Benzinga Psychedelics Capital Conference will feature a suite of the top minds in the psychedelics space. This year’s keynote speaker is Matthew W. Johnson, Ph.D., a professor of psychiatry and behavioral sciences at Johns Hopkins and a Susan Hill Ward professor in psychedelics and consciousness with over 100 published scientific manuscripts.
Additional speakers include:
Kevin Harrington, Strategic Advisor, Psycheceutical Bioscience
Bryan Passman, Co-Founder & Head Hunter, Hunter + Esquire
Courtney Barnes, Counsel, Skip Intro Advisors
Najla Guthrie, CEO, Wellbeing Digital Sciences
Joseph Tucker, CEO, Enveric Biosciences
More information about speakers may be found here:
https://www.benzinga.com/events/psychedelics/#speakers
"We've seen cannabis businesses raise hundreds of millions of dollars at our Cannabis Capital Conferences and it's exciting to once again open this possibility to businesses working to develop and establish psychedelics as the new paradigm shift in mental health treatment," says Chief Zinger Jason Raznick.
To register for the full in-person Benzinga Psychedelics Capital Conference experience, featuring networking, one-on-one meetings, access to investors and more, visit here: https://www.benzinga.com/events/psychedelics/.